Diane M. Simeone

30.5k total citations · 10 hit papers
286 papers, 20.7k citations indexed

About

Diane M. Simeone is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Diane M. Simeone has authored 286 papers receiving a total of 20.7k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Oncology, 104 papers in Molecular Biology and 64 papers in Cancer Research. Recurrent topics in Diane M. Simeone's work include Pancreatic and Hepatic Oncology Research (127 papers), Cancer Cells and Metastasis (55 papers) and Cancer Genomics and Diagnostics (53 papers). Diane M. Simeone is often cited by papers focused on Pancreatic and Hepatic Oncology Research (127 papers), Cancer Cells and Metastasis (55 papers) and Cancer Genomics and Diagnostics (53 papers). Diane M. Simeone collaborates with scholars based in United States, France and Australia. Diane M. Simeone's co-authors include Craig D. Logsdon, Chenwei Li, Michael F. Clarke, Piero Dalerba, David G. Heidt, Max S. Wicha, Charles Burant, Lanjing Zhang, Volkan Adsay and Sunitha Nagrath and has published in prestigious journals such as Nature, New England Journal of Medicine and Chemical Reviews.

In The Last Decade

Diane M. Simeone

273 papers receiving 20.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of Pancreatic Cancer Stem Cells

2007 2.6k citations Diane M. Simeone et al. Cancer Research profile →
Phenotypic characterization of human colorectal cancer stem cells

2007 1.7k citations Timothy Hoey, Austin Gurney et al. Proceedings of the National Academy of Sciences profile →
Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas

2020 626 citations Diane M. Simeone et al. profile →
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

2009 623 citations Ilona Kryczek, Linhua Vatan et al. profile →
Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells

2014 540 citations Shanshan Wan, Ende Zhao et al. profile →
Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes

2014 535 citations Diane M. Simeone, Sunitha Nagrath et al. profile →
Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment

2022 468 citations Diane M. Simeone et al. profile →
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets

2013 462 citations Diane M. Simeone, Sunitha Nagrath et al. profile →
Is There Still a Glass Ceiling for Women in Academic Surgery?

2011 388 citations Diane M. Simeone et al. profile →
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

2020 318 citations Diane M. Simeone et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diane M. Simeone United States	68	11.5k	9.9k	4.8k	3.1k	2.4k	286	20.7k
Surinder K. Batra United States	84	9.3k 0.8×	14.4k 1.5×	4.1k 0.9×	4.1k 1.3×	3.1k 1.3×	580	25.5k
Xianjun Yu China	70	9.1k 0.8×	9.9k 1.0×	6.5k 1.3×	4.0k 1.3×	2.5k 1.0×	544	21.6k
William E. Grizzle United States	82	6.3k 0.6×	14.1k 1.4×	6.4k 1.3×	3.9k 1.2×	2.0k 0.8×	499	26.2k
Emile E. Voest Netherlands	70	8.5k 0.7×	7.3k 0.7×	4.9k 1.0×	1.9k 0.6×	1.4k 0.6×	370	18.8k
William D. Figg United States	86	10.0k 0.9×	11.5k 1.2×	3.4k 0.7×	2.5k 0.8×	1.5k 0.6×	604	25.3k
Tito Fojo United States	72	13.2k 1.1×	11.7k 1.2×	4.7k 1.0×	1.1k 0.4×	3.1k 1.3×	265	24.3k
Naoto T. Ueno United States	72	11.0k 1.0×	5.6k 0.6×	6.5k 1.3×	2.6k 0.8×	1.4k 0.6×	547	20.4k
Michael S. Pepper South Africa	75	4.8k 0.4×	11.0k 1.1×	4.6k 0.9×	1.7k 0.5×	2.3k 1.0×	346	20.9k
Andrew K. Godwin United States	79	6.0k 0.5×	13.4k 1.4×	5.2k 1.1×	1.7k 0.5×	1.4k 0.6×	386	22.4k
Ann F. Chambers Canada	82	9.5k 0.8×	10.6k 1.1×	5.9k 1.2×	1.7k 0.6×	1.1k 0.5×	285	23.1k

Countries citing papers authored by Diane M. Simeone

Since Specialization

Citations

This map shows the geographic impact of Diane M. Simeone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane M. Simeone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane M. Simeone more than expected).

Fields of papers citing papers by Diane M. Simeone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane M. Simeone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane M. Simeone. The network helps show where Diane M. Simeone may publish in the future.

Co-authorship network of co-authors of Diane M. Simeone

This figure shows the co-authorship network connecting the top 25 collaborators of Diane M. Simeone. A scholar is included among the top collaborators of Diane M. Simeone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane M. Simeone. Diane M. Simeone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simeone, Diane M., Patrick Grierson, Kedar Kirtane, et al.. (2024). Improving ethnic and racial diversity in biomarker-driven clinical trials: A proof of concept with the BASECAMP-1 master prescreening study of patients with high-risk solid tumors with human leukocyte antigen-A*02 (HLA-A*02) loss of heterozygosity (LOH).. Journal of Clinical Oncology. 42(16_suppl). 1604–1604.

Punekar, Salman R., J. Randolph Hecht, Diane M. Simeone, et al.. (2024). EVEREST-2: A seamless phase 1/2 study of A2B694, a mesothelin (MSLN) logic-gated Tmod CAR T-cell therapy, in patients with solid tumors that show MSLN expression and human leukocyte antigen (HLA)-A*02 loss of heterozygosity (LOH).. Journal of Clinical Oncology. 42(16_suppl). TPS2699–TPS2699. 5 indexed citations

Su, Wenjuan, Juan Andres Kochen Rossi, Cristina Nuevo‐Tapioles, et al.. (2024). UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma. Proceedings of the National Academy of Sciences. 121(33). e2401996121–e2401996121.

Wan, Shanshan, Ende Zhao, Daniel Freeman, et al.. (2023). Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies. Frontiers in Immunology. 14. 1067352–1067352. 3 indexed citations

Oh, Grace E., Lidong Wang, Jiufeng Li, et al.. (2023). POLQ inhibition elicits an immune response in homologous recombination–deficient pancreatic adenocarcinoma via cGAS/STING signaling. Journal of Clinical Investigation. 133(11). 39 indexed citations

Anbil, Sriram, Michael Pigula, Huang‐Chiao Huang, et al.. (2020). Vitamin D Receptor Activation and Photodynamic Priming Enables Durable Low-dose Chemotherapy. Molecular Cancer Therapeutics. 19(6). 1308–1319. 39 indexed citations

Bankhead, Armand, et al.. (2018). Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers. Molecular Cancer Therapeutics. 17(12). 2495–2506. 7 indexed citations

Fedele, Carmine, Hao Ran, Brian Diskin, et al.. (2018). SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models. Cancer Discovery. 8(10). 1237–1249. 210 indexed citations

Waghray, Meghna, Malica Yalamanchili, Michele Dziubinski, et al.. (2016). GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer. Cancer Discovery. 6(8). 886–899. 152 indexed citations

10.

Palmbos, Phillip L., Lidong Wang, Huibin Yang, et al.. (2015). ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms. Cancer Research. 75(23). 5155–5166. 60 indexed citations

11.

Zhang, Yaqing, Kevin T. Kane, Meredith A. Collins, et al.. (2015). CD44 Regulates Pancreatic Cancer Invasion through MT1-MMP. Molecular Cancer Research. 13(1). 9–15. 71 indexed citations

12.

Bednar, Filip, Heather Schofield, Meredith A. Collins, et al.. (2015). Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. Carcinogenesis. 36(7). 730–738. 21 indexed citations

13.

Kim, Edward, Vaibhav Sahai, Ethan V. Abel, et al.. (2014). Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma. Clinical Cancer Research. 20(23). 5937–5945. 236 indexed citations

14.

Li, Ling, Wenhua Tang, Xiaoqing Wu, et al.. (2013). HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s. Clinical Cancer Research. 19(24). 6703–6715. 57 indexed citations

15.

Zhang, Yaqing, John P. Morris, Wei Yan, et al.. (2013). Canonical Wnt Signaling Is Required for Pancreatic Carcinogenesis. Cancer Research. 73(15). 4909–4922. 152 indexed citations

16.

Kothari, Vishal, Sunita Shankar, Shanker Kalyana‐Sundaram, et al.. (2013). Outlier Kinase Expression by RNA Sequencing as Targets for Precision Therapy. Cancer Discovery. 3(3). 280–293. 29 indexed citations

17.

Fischer, Marcus, Mark J. Hynes, Jingjiang Wu, et al.. (2012). Anti-DLL4 Has Broad Spectrum Activity in Pancreatic Cancer Dependent on Targeting DLL4-Notch Signaling in Both Tumor and Vasculature Cells. Clinical Cancer Research. 18(19). 5374–5386. 58 indexed citations

18.

Parsels, Leslie A., Yushen Qian, Daria M. Tanska, et al.. (2011). Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition. Clinical Cancer Research. 17(11). 3706–3715. 67 indexed citations

19.

Morgan, Meredith A., Leslie A. Parsels, Lili Zhao, et al.. (2010). Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair. Cancer Research. 70(12). 4972–4981. 249 indexed citations

20.

Kryczek, Ilona, Rebecca Liu, Guobin Wang, et al.. (2009). FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease. Cancer Research. 69(9). 3995–4000. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact